ALX Oncology jobs and careers
Burlingame, CA, United States
About ALX Oncology
ALX Oncology is a publicly traded, clinical-stage immuno-oncology company focused on helping patients fight cancer by developing therapies that block the CD47 checkpoint pathway and bridge the innate and adaptive immune system.
Founded in 2015 by Jaume Pons.
- Founded
- 2015
- Employees
- 11 to 50
- Total funding
- $329.2M
- Headquarters
- Burlingame
Leadership
The top of ALX Oncology's org chart, with how many people report into each leader.
Linda Woo
Senior Director Of Clinical Operations
7 reports
Athanasios Tsiatis
SVP, Clinical Development
7 reports
Lisa Sauer
Senior Vice President, Regulatory Affairs And Quality Assurance
3 reports
Hadi Falahatpisheh
Vice President, Research And Development
2 reports
Susan Vermeir
VP, Regulatory Affairs & Quality
2 reports
Jeanne Jew
Chief Business Officer
1 report
Yeong-Liang Lin
SVP, Drug Safety & Pharmacovigilance
1 report
Marija Vrljic
VP, Antibody Technologies
Hank Stern
Sr. Vice President Chemisty Manufacturing & COntrols
Emmanuel Ang
Senior Clinical Trial Manager
3 reports
Jacqueline Giang
Associate Director, Clinical Outsourcing
Avery T.
Director, Biomarker Operations
Julie Bacon
Senior Manager, Clinical Data Management
Cheng Quah
Vice President, Clincal Development
1 report
Shanhong Guan
Vice President, Head Of Biometrics
1 report
Denise Lepley
Executive Director, Clinical Science
Max
Director Of Translational Oncology - Clinical Development
Board
Keith Flaherty
Chairman, Scientific Advisory Board
Charles M. Baum
Advisor
Corey Goodman
Executive Chairman, Board of Directors
Rekha Hemrajani
Board Member
Jack B. Nielsen
Board Member
Jason Lettmann
CEO
Jobs at ALX Oncology
No open positions right now. Explore more companies on TheJobsMap.